CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Revenue (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $68M | −21.1% | 9.5% | 11.9% |
| Revenue (TTM) | $68M |
|---|---|
| YoY | −21.1% |
| 5-year CAGR | 9.5% |
| 10-year CAGR | 11.9% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $88M | +376.6% |
| 2024 | $18M | +145.3% |
| 2023 | $7.5M | −92.0% |
| 2022 | $95M | +34.3% |
| 2021 | $70M | +26.2% |
| 2020 | $56M | +107.8% |
| 2019 | $27M | −14.7% |
| 2018 | $32M | +135.6% |
| 2017 | $13M | −87.4% |
| 2016 | $106M | +271.3% |
| 2015 | $29M | −38.9% |
| 2014 | $47M | +53.2% |
| 2013 | $31M | +305.5% |
| 2012 | $7.6M | +89.0% |
| 2011 | $4.0M | +55.2% |
| 2010 | $2.6M | −96.8% |
| 2009 | $82M | — |